Search clinical trials for: Ruxolitinib cream
Total 1690 results
-
Incyte CorporationCompletedCutaneous Lichen PlanusUnited States, Canada
-
Incyte CorporationCompletedHidradenitis SuppurativaUnited States, Canada
-
Incyte CorporationCompletedLichen SclerosusUnited States, Canada
-
Incyte CorporationCompletedA Maximum Use Trial of Ruxolitinib Cream in Adolescent and Adult Participants With Atopic DermatitisAtopic DermatitisUnited States, Canada
-
Incyte CorporationRecruitingPrurigoUnited States, Spain, France, Poland, Germany, Belgium, Netherlands, Argentina, Italy, Canada, Chile, Brazil
-
Incyte CorporationInnovaderm ResearchCompleted
-
University of ZurichIncyte CorporationNot yet recruitingExanthema | Lichenoid Skin Rashes Under Anti-PD1 Tumor Therapy
-
Incyte CorporationRecruitingPrurigo NodularisKorea, Republic of, Spain, United States, Poland, Italy, Australia, Austria, Germany, Canada, Switzerland, France, Denmark, Bulgaria
-
Incyte CorporationRecruitingPrurigo NodularisUnited States
-
Milton S. Hershey Medical CenterIncyte CorporationRecruitingHidradenitis SuppurativaUnited States
-
Incyte CorporationActive, not recruitingA Study to Assess the Safety and Efficacy of Ruxolitinib Cream in Participants With Genital VitiligoNonsegmental Vitiligo With Genital InvolvementCanada, United States, France
-
Icahn School of Medicine at Mount SinaiIncyte CorporationCompleted
-
Incyte CorporationRecruiting
-
Incyte CorporationCompleted
-
Incyte CorporationCompletedAtopic DermatitisUnited States
-
Incyte CorporationCompletedAtopic DermatitisUnited States, Canada
-
Incyte CorporationCompletedVitiligoUnited States, Canada, Poland, Spain, Germany, Bulgaria, France, Netherlands
-
Incyte CorporationCompletedAtopic DermatitisUnited States
-
Tufts Medical CenterCompleted
-
Incyte CorporationCompleted
-
Memorial Sloan Kettering Cancer CenterIncyte Corporation; Hackensack Meridian HealthCompletedNon-sclerotic Cutaneous Chronic Graft-versus-host DiseaseUnited States
-
Incyte CorporationRecruitingAtopic DermatitisGermany, Poland, United States, Spain, United Kingdom, Italy, Belgium, Canada, Netherlands, Australia, Bulgaria, France, Switzerland, Hungary, Korea, Republic of
-
Incyte CorporationCompletedVitiligoUnited States, Canada, France
-
Incyte CorporationCompletedAtopic DermatitisUnited States, France, Canada, Hungary, Poland, Germany, Italy
-
Incyte CorporationCompletedAtopic DermatitisUnited States, Germany, Spain, Canada, Poland, Czechia, Bulgaria
-
Incyte CorporationActive, not recruitingAtopic Dermatitis (AD)Canada, United States, Poland
-
Incyte CorporationActive, not recruitingHand EczemaUnited States, Poland, Canada, Germany
-
Incyte CorporationWithdrawnHand EczemaUnited States, Germany, Spain, Czechia, Canada, Poland
-
Incyte CorporationWithdrawnChronic Hand Eczema (CHE)United States, Canada, Spain, Germany, Czechia, Poland, Bulgaria
-
Incyte CorporationCompletedNon-segmental VitiligoUnited States, Spain, Canada, France, Poland, Bulgaria, Germany, Italy
-
Incyte CorporationCompletedAtopic DermatitisUnited States, Canada
-
Incyte CorporationCompleted
-
Incyte CorporationCompletedNon-segmental VitiligoUnited States, Canada, Italy, France, Germany, Spain, Poland, Bulgaria, Netherlands
-
National Institute of Arthritis and Musculoskeletal...TerminatedGraft Versus Host Disease | JNS Kinase | Topical AdministrationUnited States
-
Incyte CorporationTerminatedAlopecia AreataUnited States
-
Incyte CorporationRecruitingPregnancy Related | Atopic DermatitisUnited States
-
Incyte CorporationCompletedVitiligoUnited States, Canada
-
First Affiliated Hospital of Zhejiang UniversityXiangya Hospital of Central South University; Second Affiliated Hospital, School... and other collaboratorsRecruitingHematologic Malignancy | Bronchiolitis Obliterans SyndromeChina
-
Novartis PharmaceuticalsTerminatedMyelofibrosis With High Molecular Risk MutationsBelgium, Spain, United Kingdom, Hungary, Italy, Japan, Taiwan, Germany, Canada, Singapore, Austria, Australia, France, Israel, Sweden, Switzerland, Hong Kong, Greece, Turkey, Brazil, Russian Federation, Denmark, Portugal, Norway, Poland
-
Incyte CorporationActive, not recruiting
-
Julie NangiaIncyte Corporation; Translational Breast Cancer Research ConsortiumRecruitingDuctal Carcinoma In Situ | Atypical Ductal Hyperplasia | Atypical Lobular Hyperplasia | Lobular Carcinoma In SituUnited States
-
Graceway Pharmaceuticals, LLCCompletedGenital WartsUnited States
-
Beijing Friendship HospitalUnknownHemophagocytic LymphohistiocytosisChina
-
Children's Hospital Medical Center, CincinnatiRecruitingBronchiolitis Obliterans (BO) | Hematopoietic Stem Cell Transplant (HSCT)United States
-
University of JenaCompleted
-
University of Michigan Rogel Cancer CenterCompletedHemophagocytic Syndrome (HPS)United States
-
Margherita MaffioliUnknown
-
University of PittsburghWithdrawnHead and Neck Squamous Cell Carcinoma
-
Sichuan UniversityNot yet recruitingGVHD | Acute Stem Cell Transplant ComplicationsChina
-
Multinational Center for Quality of Life Research...Not yet recruiting